Cortexyme, Inc. (NASDAQ:CRTX – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $1.18 and traded as high as $1.20. Cortexyme shares last traded at $1.15, with a volume of 36,188 shares. Cortexyme Price Performance The company has a market […]
Quince Therapeutics, Inc. (NASDAQ:QNCX – Get Free Report) Director David Lamond bought 22,327 shares of the company’s stock in a transaction on Tuesday, December 12th. The stock was bought at an average price of $1.02 per share, for a total transaction of $22,773.54. Following the completion of the purchase, the director now directly owns 2,302,291 […]
Quince Therapeutics, Inc (NASDAQ:QNCX) Director David Lamond Acquires 19,123 Shares kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Quince Therapeutics, Inc. (NASDAQ:QNCX – Get Free Report) Director David Lamond bought 19,123 shares of the firm’s stock in a transaction on Tuesday, December 5th. The shares were purchased at an average cost of $1.01 per share, with a total value of $19,314.23. Following the completion of the transaction, the director now owns 2,241,418 shares […]
Quince Therapeutics, Inc. (NASDAQ:QNCX – Get Free Report) Director David Lamond bought 19,123 shares of the stock in a transaction on Thursday, December 7th. The stock was purchased at an average price of $1.01 per share, with a total value of $19,314.23. Following the completion of the acquisition, the director now directly owns 2,279,664 shares […]